WAY-262611

Supplier: Enzo Life Sciences

BML-WN110-0005 BML-WN110-0025
76002-420EA 168.95 USD
76002-420 76002-422
WAY-262611
WAY-262611

DKK1 inhibitor


Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.

Formula: C₂₀H₂₂N₄
MW: 318.4 g/mol
MDL Number: MFCD20527803
CAS Number: 1123231-07-1
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=32a97f9c38fdf5d1dce8c9ad484f1b28a567fd4f&vid=dfae0fb9042bd050c6679c4bf429d1d3aef7bd6b&prid=web&clid=SAPDAM

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR